And social change and the impact of racism and economic growth. Its monday, june 15th and youre watching Worldwide Exchange right here on cnbc. Well, good morning, good afternoon, or good evening and welcome from anywhere in the world that you might be watching thank you for starting your week with us here on cnbc if your just joining us or waking up you might want to grab another cup of coffee. Dow futures are off their lows but theyre down 630 points right now. A couple of hours ago, dow futures were down 1,000 points all the indexes indicating a loss at the open again, a 2 drop right at the open now well see how that plays out certainly a lot of red on your screen right now lets move on. Dow futures again down 535 lets also check the etf that tracks the major averages because that is subject to different moves in the futures overall. Right now it looks about the same but we got in earlier and it looked like the possibility of limit down in the futures you want to look at those etf a
Financial position of our company it is a noncash event. Janet yellen says theres a live possibility of a december rate hike as the french bank has offset volatility around central bank policy. Based on the monetary policies regarding the fed, ecb i remain overall positive for 2016 in particular for the europe and equity asset class and especially if, as we think, we see a further improvement of the economy. British oil and gas Services Firm amec loses a fifth of its value after slashing its dividend and increasing its cost cutting. Good to have you with us today. Lets kick off the program on break news on Monetary Policy since we have been listening in closely to janet yellen and her testimony on capitol hill yesterday. Norway which surprised holding steady. So the norwegian Central Banks and key policy rate is unchanged or holding at three quarters of 1 . Last time around they surprised the market by cutting Interest Rates. What are we looking at . Strengthening back on the back of t
Growth, strengthening dollar and inflation could remain below the committees 2 target for quite some time. On wage growth, several participants believe wages didnt fall during high unemployment. Pent up wage deflation could explain modest increases in wages weve seen. They say wages could rise more rapidly Going Forward as the Unemployment Rate continues to decline. Some warn that markets may underestimate the pace and path of rate hikes once they begin. Melissa . Melissa rich, thank you so much. I want to draw attention to the chart we were looking on the screen. Market is up 105 points. We told you it was up 78. That is the s p. It is up as well. This is telling you investors like the news. What theyre hearing in it the fed will wait longer. Lets bring in the pan fell for reaction. Fox business senior correspondent, Charlie Gasparino. We have tom sullivan from fox business and from new oak asset management, Jimmy Frischling is with us. One of the things that stuck out to me, they tal
Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go easily. Y rejected the idea of a merger with teva saying it will be a cultural clash and could raise antitrust concerned and teva dismissed that today and said they could close the deal by the end of the year. The Israeli Company said they could create a transformative generic drug company with revenue of 30 billion and there could be 2 billion in cost cuts it anticipated. Teva makes the multiple s
Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go easily. Y rejected the idea of a merger with teva saying it will be a cultural clash and could raise antitrust concerned and teva dismissed that today and said they could close the deal by the end of the year. The Israeli Company said they could create a transformative generic drug company with revenue of 30 billion and there could be 2 billion in cost cuts it anticipated. Teva makes the multiple s